EDGAR Filing Documents for 0001104659-13-038892

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001104659-13-038892

Filing Date

2013-05-08

Accepted

2013-05-08 16:36:29

Documents

Period of Report

2013-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	a13-7518_110q.htm	10-Q	1191326
2	EX-10.23(III)	a13-7518_1ex10d23iii.htm	EX-10.23(III)	136301
3	EX-10.36(II)	a13-7518_1ex10d36ii.htm	EX-10.36(II)	830619
4	EX-10.39	a13-7518_1ex10d39.htm	EX-10.39	27286
5	EX-31.1	a13-7518_1ex31d1.htm	EX-31.1	11368
6	EX-31.2	a13-7518_1ex31d2.htm	EX-31.2	11412
7	EX-32.1	a13-7518_1ex32d1.htm	EX-32.1	8973
	Complete submission text file	0001104659-13-038892.txt		10221594

Data Files

Seq	Description	Document	Type	Size
8	XBRL INSTANCE DOCUMENT	onxx-20130331.xml	EX-101.INS	1011998
9	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	onxx-20130331.xsd	EX-101.SCH	104844
10	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	onxx-20130331_cal.xml	EX-101.CAL	73637
11	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	onxx-20130331_def.xml	EX-101.DEF	544506
12	XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT	onxx-20130331_lab.xml	EX-101.LAB	1734219
13	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	onxx-20130331_pre.xml	EX-101.PRE	890300

Mailing Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080

Business Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 650-266-0000

ONYX PHARMACEUTICALS INC (Filer) CIK: 0001012140 (see all company filings)